Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 1101 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1102 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 75 |
| 1103 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 1104 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 1105 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 23 |
| 1106 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 36 |
| 1107 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 1108 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 1109 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 1110 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 1111 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1112 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 58 |
| 1113 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 1114 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 1115 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
| 1116 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1117 | Bone Marrow | Allogeneic | Adenosine Deaminase Deficient Severe Combined Immunodeficiency (Ada-Scid) | Hematology | 2022 | Standard Therapy | Poland | 3 months |
| 1118 | Bone Marrow | Allogeneic | Amyloidosis | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 1119 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 19 |
| 1120 | Bone Marrow | Allogeneic | Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 1121 | Bone Marrow | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1122 | Bone Marrow | Allogeneic | Bone Marrow Failure Syndrome | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1123 | Bone Marrow | Allogeneic | Chediak-Higashi-Syndrome | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1124 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 1125 | Bone Marrow | Allogeneic | Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 1126 | Bone Marrow | Allogeneic | Common Variable Immunodeficiency With Granulomatous-Lymphocytic Interstitial Lung Disease | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1127 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1128 | Bone Marrow | Allogeneic | Diamond Blackfan Anemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
| 1129 | Bone Marrow | Allogeneic | Dock8 Deficiency | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1130 | Bone Marrow | Allogeneic | Early Isolated All Bm Relapse | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1131 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
| 1132 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 1133 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1134 | Bone Marrow | Allogeneic | Griscelli Syndrome Type 2 | Hematology | 2022 | Standard Therapy | Poland | 2 months |
| 1135 | Bone Marrow | Allogeneic | Hemophagocytic Lymphocytosis | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1136 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 1137 | Bone Marrow | Allogeneic | Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 57 |
| 1138 | Bone Marrow | Allogeneic | Infant Acute Lymphoblastic Leukemia With Kmt2a Gene Rearrangement | Hematology | 2022 | Standard Therapy | Poland | 7 months |
| 1139 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1140 | Bone Marrow | Allogeneic | Juvenile Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1141 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 1142 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1143 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 63 |
| 1144 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 1145 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 1146 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1147 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 51 |
| 1148 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 1149 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 1150 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 1151 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 1152 | Bone Marrow | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 1153 | Bone Marrow | Allogeneic | Nhl (Non-Hodgkin's Lymphoma) | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 1154 | Bone Marrow | Allogeneic | Nijmegen Breakage Syndrome | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 1155 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 1156 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1157 | Bone Marrow | Allogeneic | No Data | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1158 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 53 |
| 1159 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 1160 | Bone Marrow | Allogeneic | Osteopetrosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 1161 | Bone Marrow | Allogeneic | Other Immune System Disorders | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1162 | Bone Marrow | Allogeneic | Other Non-Malignant Disease | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 1163 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria (Pnh) | Hematology | 2022 | Standard Therapy | Poland | 17 |
| 1164 | Bone Marrow | Allogeneic | Paroxysmal Nocturnal Hemoglobinuria With Marrow Failure | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 1165 | Bone Marrow | Allogeneic | Philadelphia-Positive Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1166 | Bone Marrow | Allogeneic | Pre-B Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 32 |
| 1167 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1168 | Bone Marrow | Allogeneic | Primary Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 9 months |
| 1169 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 1170 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1171 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1172 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 1173 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 1174 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 1175 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 1176 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 1177 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1178 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 19 |
| 1179 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 1180 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1181 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 35 |
| 1182 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 1183 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 5 |
| 1184 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 30 |
| 1185 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 1186 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 1187 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 3 months |
| 1188 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2022 | Standard Therapy | Poland | 2 months |
| 1189 | Bone Marrow | Allogeneic | Shwachman-Diamond Syndrome – Sds | Hematology | 2022 | Standard Therapy | Poland | 7 |
| 1190 | Bone Marrow | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1191 | Bone Marrow | Allogeneic | Very Severe Aplastic Anemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 1192 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 1193 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 1194 | Bone Marrow | Allogeneic | X-Linked Congenital Dyskeratosis | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 1195 | Apheresis | Allogeneic | Acute Biphenotypic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 22 |
| 1196 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 1197 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 1198 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
| 1199 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 29 |
| 1200 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 59 |